Cargando…
Tyrphostin AG 1296 induces glioblastoma cell apoptosis in vitro and in vivo
Glioblastoma is the most common type of malignant human brain tumor. Currently available chemotherapies for glioblastoma focus on targeting tyrosine kinases. However, the existing inhibitors of tyrosine kinases have not produced the therapeutic outcomes that were anticipated. In order to investigate...
Autores principales: | LI, HONGWEI, ZHENG, JUNNING, GUAN, RUIYUN, ZHU, ZIFENG, YUAN, XIANHOU |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665272/ https://www.ncbi.nlm.nih.gov/pubmed/26788146 http://dx.doi.org/10.3892/ol.2015.3781 |
Ejemplares similares
-
Cytostatic and cytotoxic effects of tyrphostin AG1296 on RMS cells
por: Lasota, Małgorzata, et al.
Publicado: (2012) -
Tyrphostin AG1296, a platelet-derived growth factor receptor inhibitor, induces apoptosis, and reduces viability and migration of PLX4032-resistant melanoma cells
por: Li, Yanling, et al.
Publicado: (2015) -
Tyrphostin AG17 inhibits adipocyte differentiation in vivo and in vitro
por: Camacho, Alberto, et al.
Publicado: (2018) -
Additive effect by combination of Akt inhibitor, MK-2206, and PDGFR inhibitor, tyrphostin AG 1296, in suppressing anaplastic thyroid carcinoma cell viability and motility
por: Che, Huan-yong, et al.
Publicado: (2014) -
Inhibition of zymosan-induced kidney dysfunction by tyrphostin AG-490
por: Dimitrova, Petya, et al.
Publicado: (2009)